Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.

Hayakawa, Kayoko

Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. [electronic resource] - Antimicrobial agents and chemotherapy Jul 2014 - 3968-75 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.02943-14 doi


Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents--economics
Bacteremia--drug therapy
Cohort Studies
Daptomycin--economics
Female
Gram-Positive Bacterial Infections--drug therapy
Hospital Costs
Humans
Linezolid--economics
Male
Microbial Sensitivity Tests
Middle Aged
Severity of Illness Index
Vancomycin Resistance--drug effects
Vancomycin-Resistant Enterococci--drug effects
beta-Lactams--economics